Binlong Chen
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 18
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 32
- Graphene and Nanomaterials Applications 4
- Immunology top 5%
- Pharmaceutical Science top 5%
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 6
-
- Animal Nutrition and Physiology 8
-
- Photodynamic Therapy Research Studies 7
-
- Luminescence and Fluorescent Materials 5
- Porphyrin and Phthalocyanine Chemistry 4
- Partner nations
- ChinaUnited States
In The Last Decade
Binlong Chen
80 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Biomaterials 777
- Biomedical Engineering 1.4k
- Immunology 431
- Pharmaceutical Science 94
- Molecular Biology 1.0k
Countries citing papers authored by Binlong Chen
This map shows the geographic impact of Binlong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binlong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binlong Chen more than expected).
Fields of papers citing papers by Binlong Chen
This network shows the impact of papers produced by Binlong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binlong Chen. The network helps show where Binlong Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Binlong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 14 | |
| 5 | 2024 | 17 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 35 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 1 | |
| 12 | A pyroptosis nanotuner for cancer therapybreakdown → | 2022 | 217 |
| 13 | 2022 | 11 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 32 | |
| 16 | 2021 | 3 | |
| 17 | 2020 | 79 | |
| 18 | 2019 | 5 | |
| 19 | 2019 | 24 | |
| 20 | 2018 | 61 |
About Binlong Chen
Binlong Chen is a scholar working on Biomaterials, Animal Science and Zoology and Biomedical Engineering, having authored 86 papers that have together received 2.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (32 papers), Nanoparticle-Based Drug Delivery (18 papers), Animal Nutrition and Physiology (8 papers), Photodynamic Therapy Research Studies (7 papers), RNA Interference and Gene Delivery (6 papers), Luminescence and Fluorescent Materials (5 papers), Graphene and Nanomaterials Applications (4 papers) and Porphyrin and Phthalocyanine Chemistry (4 papers). The work is most often cited by research in Biomaterials (777 citations), Biomedical Engineering (1.4k citations) and Immunology (431 citations). Binlong Chen has collaborated with scholars based in China and United States. Frequent co-authors include Qiang Zhang, Yiguang Wang, Bing He, Wenbing Dai, Xueqing Wang, Hua Zhang, Qingqing Yin, Zenghui Wang, Yue Yan and Yaoqi Wang. Their work appears in journals such as Nature Communications, Animals, Advanced Functional Materials, Scientific Reports and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.